SCHEMBL6566499

SCHEMBL6566499

CC[C@H](C)NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 2/20 0.52
ALDH1A1 P00352 2/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CYP3A4 P08684 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
HIF1A Q16665 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CACNA1F O60840 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA2B P18089 1/20 0.40
CHRM3 P20309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16609226 1.00 KCNN4 (0.52) KCNN4ALDH1A1RAB9ASMN1; SMN2TP53
SCHEMBL15398804 0.87 KCNN4 (0.41) KCNN4ALDH1A1RAB9ASMN1; SMN2CYP3A4
SCHEMBL3661357 0.83 KCNN4 (0.42) KCNN4ALDH1A1RAB9ASMN1; SMN2TP53
SCHEMBL14613732 0.82 KCNN4 (0.42) KCNN4ALDH1A1SMN1; SMN2HSD17B10TDP1
SCHEMBL24453542 0.82 CACNA1F (0.43) KCNN4ALDH1A1RAB9ASMN1; SMN2TP53
SCHEMBL10053574 0.82 KCNN4 (0.50) KCNN4ALDH1A1RAB9ATSHRHSD17B10
SCHEMBL18799433 0.79 CACNA1F (0.44) KCNN4ALDH1A1RAB9ASMN1; SMN2TP53
SCHEMBL28513998 0.79 KCNN4 (0.42) KCNN4ALDH1A1RAB9ASMN1; SMN2HSD17B10
SCHEMBL27365381 0.78 KCNN4 (0.54) KCNN4ALDH1A1CYP3A4THRBALOX15
SCHEMBL16550481 0.78 KCNN4 (0.50) KCNN4ALDH1A1HIF1AHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1399446-A1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2004-03-24 EP disclosed
WO-2003002565-A1 2,6,9-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE N THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2003-01-09 WO disclosed